Singapore: +65-31631880 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719

          

Regulatory Affairs Singapore

Economies are shifting all over the world, clearing the boundaries between developed and developing nations. With tough economic times being experienced, and debt raising in many nations globally, there is uncertainty abound. Many prosperous nations are beginning to see their prosperity slipping and it is creating mistrust and chaos in many business industries. None is on the verge of collapse more than the healthcare and pharmaceutical industries. With so much regulation being imposed on them in other regions of the world, they are beginning to see that existing and operating in some developed nations, is not worth the high cost.


There are good reasons why healthcare and pharmaceutical research is so heavily monitored. But, there are good reasons for regulation, and unnecessary ones. Unfortunately, the lines are beginning to blur, and many are experiencing such heavy red tape and overregulation that it is slowing down, or halting the production of furthering the development of many life saving medications, and technological advances. Overregulation is more related to fees, governmental taxes, and ideology than any real reason for the regulations themselves. That is driving many companies and business owners to explore the potential of moving their operations out of their native countries. They are exploring finding new host countries to prosper.


Being able to get the same high quality standards and production in a third world nation, many business are exploring the potential of relocating to third world nations like Singapore. Being quickly thrust into the International stage, Singapore is becoming one of the best options for healthcare and pharmaceutical industries to begin their prosperity, and to begin production on the clinical research, that is so important to world health overall.


The regulatory affairs of Singapore are different than other regions of the world. Adhering to strict laws about the treatment of patients for clinical care, they do no impose unnecessary rules that bog down the system, or make it impossible for companies to operate in a successful manner. They hold strict constraints to limit the potential for harm to patients, or unethical procedures, but that is where their regulation ends. They understand the boundaries between being safe, and being an imposition, and holding up the procedures that are so necessary for the good of the human race.


Over the next decade there is going to be a great demand for those in Singapore who are trained and educated in medicine and medical research. How big a part Singapore plays on the healthcare International stage remains to be seen, but the promise for great career advancement and to make a name for itself as a great producer of research, is real and present.



James Lind Institute Newsletter
James Lind Institute Youtube
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Facebook